CHOP and R-CHOP Therapeutic Responses in Non-HODGKIN Lymphoma Patients in Dr. Soetomo General Hospital Surabaya

• Main Authors: Rina Syarifah Salma, Made Putra Sedana, Siprianus Ugroseno Yudho Bintoro
• Format: Article PeerReviewed
• Language: English; English; English
• Published: Faculty of Medicine Universitas Airlangga 2018
• Subjects: R Medicine (General); RC Internal medicine
• Online Access: http://repository.unair.ac.id/96249/1/CHOP%20and%20R-CHOP%20Therapeutic%20Responses%20in%20NonHodgkin%20Lymphoma%20Patients%20in%20Dr.%20Soetomo%20general%20hospital%20surabaya.pdf; http://repository.unair.ac.id/96249/2/CHOP%20and%20R-CHOP%20Therapeutic.pdf; http://repository.unair.ac.id/96249/3/CHOP%20and%20R-CHOP%20Therapeutic%20Responses%20in%20NonHodgkin%20Lymphoma%20Patients%20in%20Dr.%20Soetomo%20general%20hospital%20surabaya.pdf; http://repository.unair.ac.id/96249/; https://e-journal.unair.ac.id/BHSJ/article/view/9244; http://dx.doi.org/10.20473/bhsj.v1i2.9244
• Institution: Universitas Airlangga

Introduction: Non-Hodgkin Lymphoma (NHL) is a group of lymphoid-derived malignant disease with heterogenic biological and clinical manifestations. For over 30 years, CHOP (Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone) has been the first choice of chemotherapy for aggressive NHL. Later...